UA104870C2 - Стабільна пероральна тверда композиція поліпептидного агоніста gc-c рецептора лінаклотиду та спосіб її одержання - Google Patents
Стабільна пероральна тверда композиція поліпептидного агоніста gc-c рецептора лінаклотиду та спосіб її одержанняInfo
- Publication number
- UA104870C2 UA104870C2 UAA201103016A UAA201103016A UA104870C2 UA 104870 C2 UA104870 C2 UA 104870C2 UA A201103016 A UAA201103016 A UA A201103016A UA A201103016 A UAA201103016 A UA A201103016A UA 104870 C2 UA104870 C2 UA 104870C2
- Authority
- UA
- Ukraine
- Prior art keywords
- heading
- formulation
- cys
- preparing
- oral administration
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title abstract 6
- 239000000203 mixture Substances 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 2
- 229920001184 polypeptide Polymers 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 239000007787 solid Substances 0.000 title abstract 2
- 102000000820 Enterotoxin Receptors Human genes 0.000 title 1
- 108010001687 Enterotoxin Receptors Proteins 0.000 title 1
- 239000000018 receptor agonist Substances 0.000 title 1
- 229940044601 receptor agonist Drugs 0.000 title 1
- KXGCNMMJRFDFNR-WDRJZQOASA-N linaclotide Chemical compound C([C@H](NC(=O)[C@@H]1CSSC[C@H]2C(=O)N[C@H]3CSSC[C@H](N)C(=O)N[C@H](C(N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N2)=O)CSSC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC3=O)C(=O)N[C@H](C(NCC(=O)N1)=O)[C@H](O)C)C(O)=O)C1=CC=C(O)C=C1 KXGCNMMJRFDFNR-WDRJZQOASA-N 0.000 abstract 3
- 108010024409 linaclotide Proteins 0.000 abstract 3
- 229960000812 linaclotide Drugs 0.000 abstract 3
- PLTGTJAZQRGMPP-FXQIFTODSA-N Asn-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(N)=O PLTGTJAZQRGMPP-FXQIFTODSA-N 0.000 abstract 1
- ISWAQPWFWKGCAL-ACZMJKKPSA-N Cys-Cys-Glu Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(O)=O ISWAQPWFWKGCAL-ACZMJKKPSA-N 0.000 abstract 1
- ALNKNYKSZPSLBD-ZDLURKLDSA-N Cys-Thr-Gly Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O ALNKNYKSZPSLBD-ZDLURKLDSA-N 0.000 abstract 1
- CGDZGRLRXPNCOC-SRVKXCTJSA-N Tyr-Cys-Cys Chemical compound SC[C@@H](C(O)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 CGDZGRLRXPNCOC-SRVKXCTJSA-N 0.000 abstract 1
- 150000001413 amino acids Chemical group 0.000 abstract 1
- 108010010430 asparagine-proline-alanine Proteins 0.000 abstract 1
- 108010069495 cysteinyltyrosine Proteins 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02W—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT
- Y02W90/00—Enabling technologies or technologies with a potential or indirect contribution to greenhouse gas [GHG] emissions mitigation
- Y02W90/10—Bio-packaging, e.g. packing containers made from renewable resources or bio-plastics
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8942208P | 2008-08-15 | 2008-08-15 | |
| PCT/US2009/004675 WO2010019266A2 (en) | 2008-08-15 | 2009-08-14 | Stable solid formulation of a gc-c receptor agonist polypeptide suitable for oral administration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA104870C2 true UA104870C2 (uk) | 2014-03-25 |
Family
ID=56267523
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201103016A UA104870C2 (uk) | 2008-08-15 | 2009-08-14 | Стабільна пероральна тверда композиція поліпептидного агоніста gc-c рецептора лінаклотиду та спосіб її одержання |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR118601A2 (es) |
| UA (1) | UA104870C2 (es) |
-
2009
- 2009-08-14 UA UAA201103016A patent/UA104870C2/uk unknown
-
2020
- 2020-04-06 AR ARP200100962A patent/AR118601A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR118601A2 (es) | 2021-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12015501579B1 (en) | Stable solid formulation of a gc-c receptor agonist polypeptide suitable for oral administration | |
| WO2010027405A3 (en) | Formulations of gc-c receptor agonist polypeptides | |
| US8507447B2 (en) | Treatments for gastrointestinal disorders | |
| US20210388026A1 (en) | Treatments for Gastrointestinal Disorders | |
| US20190062376A1 (en) | Treatments for Gastrointestinal Disorders | |
| US8748575B2 (en) | Therapeutic peptides | |
| WO2008030968A3 (en) | Fusion peptide therapeutic compositions | |
| WO2007149334A3 (en) | Vegf antagonist formulations suitable for intravitreal administration | |
| CY1116980T1 (el) | Φαρμακοτεχνικες μορφες ανταγωνιστη του vegf | |
| WO2010129469A8 (en) | Stable high protein concentration formulations of human anti-tnf-alpha-antibodies | |
| NZ621868A (en) | Growth hormone polypeptides and methods of making and using same | |
| US20130130995A1 (en) | Treatments for Gastrointestinal Disorders | |
| MY160652A (en) | Pharmaceutical composition for oral administration | |
| US20160324968A1 (en) | Linaclotide compositions | |
| WO2006023665A3 (en) | Il-1 antagonist formulations | |
| PH12022551101A1 (en) | Npy2 receptor agonists | |
| CR20230074A (es) | Agonistas del receptor npy2 solubles | |
| WO2007061829A3 (en) | Pharmaceutical composition | |
| AU2019284019A1 (en) | Agonists of guanylate cyclase useful for the treatment of opioid induced dysfunctions | |
| CN102272151A (zh) | Crhr2肽激动剂及其用途 | |
| UA104870C2 (uk) | Стабільна пероральна тверда композиція поліпептидного агоніста gc-c рецептора лінаклотиду та спосіб її одержання | |
| WO2007022254A3 (en) | Pharmaceutical formulations for sustained drug delivery | |
| UY32054A (es) | Formulación sólida estable de un polipéptido agonista de receptor gc-c adecuado para administración oral. | |
| ECSP11010897A (es) | Formulación sólida estable de un polipéptido agonista de receptor | |
| CA3177220A1 (en) | Liquid pharmaceutical formulations polyethylene glycol-based prodrugs of adrenomedullin and use |